Picture of Essex Bio-Technology logo

1061 — Essex Bio-Technology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Brief: Essex Bio-Technology Says Approval To Commercialise Eye Drops From NMPA

Dec 24 (Reuters) - Essex Bio-Technology Ltd  1061.HK :
    * APPROVAL TO COMMERCIALISE PRESERVATIVE-FREE UNIT-DOSE
SODIUM
HYALURONATE EYE DROPS (0.1%) IN CHINA FROM NMPA


Further company coverage:  1061.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Essex Bio-Technology

See all news